NCT01889368View on ClinicalTrials.gov

Effect of a Grape Seed Extract (GSE) on Insulin Resistance

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Grape Seed Extract

300 mg capsule of Grape Seed Extract; 1 capsule will be consumed for an acute post-prandial study day and 1 capsule will be consumed daily for 30 days.

DIETARY_SUPPLEMENT

Placebo

300 mg capsule of maltodextrin; 1 capsule will be consumed for an acute post-prandial study day and 1 capsule will be consumed daily for 30 days.

Trial Locations (1)

95655

VA Hospital, Mather, Mather

All Listed Sponsors
collaborator

Illinois Institute of Technology

OTHER

lead

University of California, Davis

OTHER

NCT01889368 - Effect of a Grape Seed Extract (GSE) on Insulin Resistance | Biotech Hunter | Biotech Hunter